ciliobrevin-a and Skin-Neoplasms

ciliobrevin-a has been researched along with Skin-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for ciliobrevin-a and Skin-Neoplasms

ArticleYear
Advanced basal cell carcinoma treated with vismodegib: impact on the lives of patients and their families.
    Clinical and experimental dermatology, 2020, Volume: 45, Issue:8

    Locally advanced basal cell carcinoma (laBCC) represented an uncommon, difficult-to-treat form of skin cancer until the recent approval of the Hedgehog inhibitor vismodegib. Approximately 80% of laBCCs occur in the head and neck region, causing disfiguring skin changes that have an impact on patient quality of life (QoL). Because the lives of patients with advanced BCCs are severely disrupted, it would be expected that the QoL family members involved in caregiving would also be affected. The aim of our study was to quantify the QoL of both patients and family members during vismodegib treatment using the Dermatology Life Quality Index and the Family Dermatology Life Quality Index, respectively.

    Topics: Aged; Anilides; Carcinoma, Basal Cell; Family; Female; Hedgehog Proteins; Humans; Male; Middle Aged; Patients; Psychological Distress; Pyridines; Quality of Life; Quinazolinones; Skin Neoplasms; Surveys and Questionnaires

2020